StockData
Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO) stock

INONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$1.69+0.06 (+3.68%)

Close on Nov 18, 2026Market cap $174.74MP/E –Yield –

Inovio Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Inovio Pharmaceuticals's price to book ratio was 27.8× on Nov 11, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 0.6× to 27.8×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202627.8×+24.8
2025Oct 31, 20253.0×+2.4
2024Dec 31, 20240.6×−0.3
2023Dec 29, 20231.0×−0.5
2022Dec 30, 20221.5×−0.9
2021Dec 31, 20212.3×−2.3
2020Dec 31, 20204.6×−5.1
2019Dec 31, 20199.7×+6.1
2018Dec 31, 20183.6×+1.3
2017Dec 29, 20172.3×−1.2
2016Dec 30, 20163.5×+1.0
2015Dec 31, 20152.5×−2.2
2014Dec 31, 20144.8×−5.0
2013Dec 31, 20139.7×+7.6
2012Dec 31, 20122.2×+0.7
2011Jul 29, 20111.4×–

More Inovio Pharmaceuticals figures

See a number that looks wrong?